STERIS plc — Director's Dealing 2020

Sep 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2020-09-15

Reporting Person: Carestio Daniel A (Sr VP and Chief Operating Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-15	Ordinary Shares	M	8000	$67.98	Acquired	34314	Direct
2020-09-15	Ordinary Shares	S	1039	$168.94	Disposed	33275	Direct
2020-09-15	Ordinary Shares	S	6750	$169.66	Disposed	26525	Direct
2020-09-15	Ordinary Shares	S	211	$170.31	Disposed	26314	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-15	Employee Stock Option (right to buy)	$67.98	M	8000	Acquired	2025-08-10	Ordinary Shares (8000)	Direct

Footnotes

F1: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024.

F2: This exercise of stock options and sale of a total of 1,039 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.

F3: Price reflects a weighted average sale price for multiple transactions ranging from $168.17 to $169.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: This exercise of stock options and sale of a total of 6,750 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.

F5: Price reflects a weighted average sale price for multiple transactions ranging from $169.22 to $170.2150 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6: This exercise of stock options and sale of a total of 211 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020.

F7: Price reflects a weighted average sale price for multiple transactions ranging from $170.2650 to $170.34 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8: This option to purchase 8,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 8,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.